Your browser doesn't support javascript.
loading
HER2 low expression breast cancer subtyping and their correlation with prognosis and immune landscape based on the histone modification related genes.
Li, Jia; Yao, Jingchun; Qi, Liqiang.
Afiliação
  • Li J; Department of Breast Surgical Oncology, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Xinghualing District, Taiyuan, 030013, Shanxi Province, People's Republic of China.
  • Yao J; Department of Head and Neck, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Xinghualing District, Taiyuan, 030013, Shanxi Province, People's Republic of China.
  • Qi L; Department of Breast Surgical Oncology, Cancer Institute and Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No.17 Panjiayuan, Huawei South Road, Chaoyang District, Beijing, 100021, People's Republic of China. qi_liqiang@outlook.com.
Sci Rep ; 13(1): 21753, 2023 12 08.
Article em En | MEDLINE | ID: mdl-38066224

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor ErbB-2 / Código das Histonas Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptor ErbB-2 / Código das Histonas Idioma: En Ano de publicação: 2023 Tipo de documento: Article